Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single and Multiple Assending Doses Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamic Characteristics and Food Effect After Administration of HHT120 Capsule in Healthy Subjects

NCT05414734 is registered in ClinicalTrials.gov with Shanghai Synergy Pharmaceutical Sciences Co., Ltd. as lead sponsor.

NCT NCT05414734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05414734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single and Multiple Assending Doses Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamic Characteristics and Food Effect After Administration of HHT120 Capsule in Healthy Subjects
Lead sponsor
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
Phase
Phase 1
Overall status
Withdrawn
Start date
July 1, 2022
Completion date
March 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy